RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more
RPG Life Sciences Limited (RPGLIFE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.020x
Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹112.70 Million) by net assets (₹5.54 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
RPG Life Sciences Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rekor Systems Inc
NASDAQ:REKR
|
-0.133x |
|
Northern Minerals Limited
PINK:NOURF
|
-6.457x |
|
Esso S.A.F.
PA:ES
|
-0.040x |
|
Japan System Techniques Co. Ltd.
PINK:JAPPF
|
-0.083x |
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
-0.155x |
|
Userjoy Technology Co Ltd
TWO:3546
|
0.008x |
|
Verkkokauppa.com Oyj
HE:VERK
|
-0.010x |
|
KALTURA INC. DL -0001
F:73Q
|
N/A |
Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹5.31 Billion | ₹778.60 Million | 0.147x | -41.70% |
| 2024-03-31 | ₹3.75 Billion | ₹943.60 Million | 0.252x | -14.74% |
| 2023-03-31 | ₹3.08 Billion | ₹908.20 Million | 0.295x | +16.63% |
| 2022-03-31 | ₹2.56 Billion | ₹647.50 Million | 0.253x | -5.96% |
| 2021-03-31 | ₹2.16 Billion | ₹582.70 Million | 0.269x | -5.25% |
| 2020-03-31 | ₹1.77 Billion | ₹501.70 Million | 0.284x | -0.38% |
| 2019-03-31 | ₹1.60 Billion | ₹457.80 Million | 0.285x | +200.68% |
| 2018-03-31 | ₹1.55 Billion | ₹146.80 Million | 0.095x | +93.85% |
| 2017-03-31 | ₹1.54 Billion | ₹75.40 Million | 0.049x | -80.08% |
| 2016-03-31 | ₹1.34 Billion | ₹328.10 Million | 0.246x | +1660.38% |
| 2015-03-31 | ₹1.25 Billion | ₹-19.70 Million | -0.016x | +64.40% |
| 2014-03-31 | ₹1.26 Billion | ₹-55.60 Million | -0.044x | -127.36% |
| 2013-03-31 | ₹762.30 Million | ₹123.20 Million | 0.162x | -23.92% |
| 2012-03-31 | ₹741.40 Million | ₹157.50 Million | 0.212x | +10.23% |
| 2011-03-31 | ₹748.31 Million | ₹144.21 Million | 0.193x | -39.62% |
| 2010-03-31 | ₹644.31 Million | ₹205.66 Million | 0.319x | -39.17% |
| 2009-03-31 | ₹549.21 Million | ₹288.19 Million | 0.525x | -4.46% |
| 2008-03-31 | ₹492.02 Million | ₹270.23 Million | 0.549x | +166.15% |
| 2007-03-31 | ₹742.36 Million | ₹153.19 Million | 0.206x | +67.70% |
| 2006-03-31 | ₹667.72 Million | ₹82.17 Million | 0.123x | -71.98% |
| 2005-03-31 | ₹150.60 Million | ₹66.13 Million | 0.439x | -- |